• APALUTAMIDE chembl:CHEMBL3183409 ApprovedAntineoplastic

    Alternate Names:

    ARN-509
    APALUTAMIDE
    ERLEADA
    JNJ-56021927
    ARN509
    chembl:CHEMBL3183409
    pubchem.compound:24872560
    chemidplus:956104-40-8

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    Drug Type small molecule
    Drug Groups approved
    Drug Groups investigational
    Drug Categories antiandrogens
    Drug Categories antineoplastic agents
    Drug Categories antineoplastic and immunomodulating agents
    Drug Categories bcrp/abcg2 inducers
    Drug Categories cytochrome p-450 cyp2c19 inducers
    Drug Categories cytochrome p-450 cyp2c19 inducers (strong)
    Drug Categories cytochrome p-450 cyp2c8 substrates
    Drug Categories cytochrome p-450 cyp2c9 inducers
    Drug Categories cytochrome p-450 cyp2c9 inducers (weak)
    Drug Categories cytochrome p-450 cyp3a inducers
    Drug Categories cytochrome p-450 cyp3a inducers (strong)
    Drug Categories cytochrome p-450 cyp3a substrates
    Drug Categories cytochrome p-450 cyp3a4 inducers
    Drug Categories cytochrome p-450 cyp3a4 inducers (strong)
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 enzyme inducers
    Drug Categories cytochrome p-450 substrates
    Drug Categories drugs that are mainly renally excreted
    Drug Categories endocrine therapy
    Drug Categories hormone antagonists and related agents
    Drug Categories imidazoles
    Drug Categories imidazolidines
    Drug Categories mate 1 inhibitors
    Drug Categories mate 2 inhibitors
    Drug Categories mate inhibitors
    Drug Categories oat3/slc22a8 inhibitors
    Drug Categories oatp1b1/slco1b1 inducers
    Drug Categories oct2 inhibitors
    Drug Categories p-glycoprotein inducers
    Drug Categories prostatic neoplasms, drug therapy
    (4 More Sources)